Entrada Therapeutics, Inc. (TRDA) stock
Close on Nov 12, 2026Market cap $201.30MP/E –Yield –
Entrada Therapeutics statistics
75 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 25, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 1.02
- 2.29
Enterprise valuationIndustry
- EV / Sales
- 2.09
- 2.60
Share statisticsIndustry
- Shares Change (YoY)
- 0.54%
- 10.9%
- Shares Change (QoQ)
- 0.55%
- 0.48%
- Float
- 33M
- 49M
- Shares Held by Insiders
- 14.8%
- 12.1%
- Shares Held by Institutions
- 75.6%
- 56.4%
Short sellingIndustry
- Short Interest
- 3M
- –
- Short Interest Change
- -14.2%
- -0.76%
- Short % of Float
- 8.46%
- 9.06%
- Short % of Shares Outstanding
- 7.21%
- 6.30%
- Days to Cover
- 6.88
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $16.45
- –
- 52-Week Low
- $4.11
- –
- 20-Day Moving Average
- $4.79
- –
- 50-Day Moving Average
- $5.64
- –
- 200-Day Moving Average
- $8.49
- –
- Average True Range (14)
- $0.49
- –
- Price Change (1 Week)
- 13.6%
- 1.51%
- Price Change (1 Month)
- 13.6%
- -2.37%
- Price Change (3 Months)
- -30.7%
- -21.1%
- Price Change (6 Months)
- -24.3%
- -22.8%
- Price Change (YTD)
- -49.7%
- -22.6%
- Price Change (1 Year)
- -32.9%
- -21.0%
- Price Change (3 Years)
- -68.5%
- -24.8%
- Price Change (5 Years)
- -84.0%
- -76.9%
- Average Volume (10 Days)
- 547,396
- –
- Average Volume (20 Days)
- 486,550
- –
- Average Volume (90 Days)
- 388,759
- –
- Relative Volume
- 2.10
- 0.80
- Relative Strength Index (14)
- 50.8
- 44.7
- Volatility (1 Year)
- 91.2%
- 80.2%
- Beta (5 Years)
- 0.96
- 1.07
MarginsIndustry
- EBITDA Margin
- -4303.8%
- -27.7%
- FCF Margin
- -3428.1%
- -8.85%
Returns on capitalIndustry
- Return on Equity (ROE)
- -59.9%
- -51.3%
- Return on Assets (ROA)
- -47.5%
- -40.7%
- Return on Invested Capital (ROIC)
- -1405.5%
- -32.9%
- Return on Capital Employed (ROCE)
- -71.0%
- -38.1%
Financial positionIndustry
- Current Ratio
- 7.85
- 3.31
- Quick Ratio
- 7.46
- 2.41
GrowthIndustry
- Revenue Growth (YoY)
- -93.5%
- 7.26%
EfficiencyIndustry
- Asset Turnover
- 0.01
- 0.40
- Revenue Per Employee
- $26.16K
- $429.38K
- Profits Per Employee
- -$1.06M
- -$683.67K
- Employee Count
- 152
- 75
- WACC
- 9.68%
- 10.0%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $193.00M
- $16.98M
- Net Cash Per Share
- $4.96
- $0.72
- Equity (Book Value)
- $198.33M
- $52.68M
- Book Value Per Share
- $5.09
- $1.50
- Tangible Book Value
- $198.33M
- $26.74M
- Working Capital
- $177.09M
- $78.52M
Cash flow (TTM)Industry
- Capital Expenditures
- -$9.00K
- -$944.00K
- FCF Per Share
- -$3.50
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -80.2%
- -21.0%
- FCF Yield
- -67.7%
- -9.44%
Taxes and interestIndustry
- Income Tax
- $192.00K
- $74.00K
Scores and fair valueIndustry
- Altman Z-Score
- -1.62
- 0.26
- Piotroski F-Score
- 2
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | TRDA | S&P 500 | Difference | TRDA per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -6.0% | -2.7% | −3.3 pts | ||
| 3 months | -32.6% | -1.7% | −30.8 pts | ||
| Year to date | -49.7% | +11.9% | −61.6 pts | ||
| 1 year | -35.5% | +12.0% | −47.4 pts | ||
| 3 years | -68.9% | +78.2% | −147.1 pts | -32.3% | +21.2% |
| 5 years | -84.0% | +73.2% | −157.3 pts | -30.7% | +11.6% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
3M TRDA shares were sold short on Oct 30, 2026, down 14.2% from the previous report, or 8.46% of the shares available to trade. At recent volumes it would take 6.9 days to buy them back. Over the last 20 sessions, 41.5% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 2,807,309 | -14.2% | 408,246 | 6.9 |
| Oct 15, 2026 | 3,271,781 | +9.4% | 380,605 | 8.6 |
| Sep 30, 2026 | 2,989,455 | +8.9% | 303,169 | 9.9 |
| Sep 15, 2026 | 2,744,145 | +17.0% | 340,415 | 8.1 |
| Aug 31, 2026 | 2,345,803 | -0.9% | 219,451 | 10.7 |
| Aug 14, 2026 | 2,367,019 | +10.4% | 384,854 | 6.2 |
| Jul 31, 2026 | 2,143,736 | -3.9% | 494,747 | 4.3 |
| Jul 15, 2026 | 2,230,697 | +5.6% | 356,582 | 6.3 |
| Jun 30, 2026 | 2,111,685 | +10.4% | 360,809 | 5.8 |
| Jun 15, 2026 | 1,913,294 | +10.8% | 239,128 | 8.0 |
| May 29, 2026 | 1,727,002 | +14.5% | 386,626 | 4.5 |
| May 15, 2026 | 1,507,737 | +51.0% | 972,065 | 1.6 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?